<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="sca17" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">sca17</book-part-id>
      <title-group>
        <title>Spinocerebellar Ataxia Type 17</title>
        <alt-title alt-title-type="alt-title">Synonyms: SCA17, HDL4, Huntington Disease-Like 4</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Toyoshima</surname>
            <given-names>Yasuko</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Associate Professor, Department of Pathology <break/>Brain Research Institute <break/>Niigata University <break/>Niigata, Japan</aff>
          <email>yasuko@bri.niigata-u.ac.jp</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Onodera</surname>
            <given-names>Osamu</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Professor, Department of Molecular Neuroscience <break/>Brain Research Institute <break/>Niigata University <break/>Niigata, Japan</aff>
          <email>onodera@bri.niigata-u.ac.jp</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Yamada</surname>
            <given-names>Mitsunori</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Department of Clinical Research<break/>Saigata National Hospital<break/>National Hospital Organization<break/>Niigata, Japan</aff>
          <email>nori@saigata-nh.go.jp</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tsuji</surname>
            <given-names>Shoji</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Professor, Department of Neurology <break/>University of Tokyo Graduate School of Medicine <break/>Tokyo, Japan</aff>
          <email>tsuji@m.u-tokyo.ac.jp</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Takahashi</surname>
            <given-names>Hitoshi</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Professor, Department of Pathology <break/>Brain Research Institute <break/>Niigata University <break/>Niigata, Japan</aff>
          <email>hitoshi@bri.niigata-u.ac.jp</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>29</day>
          <month>3</month>
          <year>2005</year>
        </date>
        <date date-type="updated">
          <day>17</day>
          <month>5</month>
          <year>2012</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="sca15" document-type="chapter">Spinocerebellar Ataxia Type 15</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="sca20" document-type="chapter">Spinocerebellar Ataxia Type 20</related-object>
      <abstract id="sca17.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Spinocerebellar ataxia type 17 (SCA17) is characterized by ataxia, dementia, and involuntary movements, including chorea and dystonia. Psychiatric symptoms, pyramidal signs, and rigidity are common. The age of onset ranges from three to 55 years. Individuals with full-penetrance alleles develop neurologic and/or psychiatric symptoms by age 50 years. Ataxia and psychiatric abnormalities are frequently the initial findings, followed by involuntary movement, parkinsonism, dementia, and pyramidal signs. Brain MRI shows variable atrophy of the cerebrum, brain stem, and cerebellum. The clinical features correlate with the length of the polyglutamine expansion but are not absolutely predictive of the clinical course.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of SCA17 relies on molecular genetic testing to detect an abnormal CAG/CAA repeat expansion in <italic toggle="yes">TBP</italic>, the only gene in which mutation is known to cause SCA17. Affected individuals usually have more than 42 repeats. Such testing detects 100% of affected individuals. The CAA and CAG codons both encode glutamine residues resulting in a pathogenic polyglutamine expansion.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> psychotropic medications for psychiatric problems, antiepileptic drugs for seizures (AEDs); botulinum toxin injections for dystonia; and adaptation of the environment to accommodate dementia.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Side effects of psychotropic medications and AEDs may require total or intermittent discontinuation of the treatment or reduction in dose.</p>
          <p><italic toggle="yes">Surveillance:</italic> Annual or semiannual evaluation by a neurologist or more frequently if symptoms are progressing rapidly.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Sedative/hypnotic agents, such as ethanol or certain medications, may exacerbate incoordination.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>SCA17 is inherited in an autosomal dominant manner. Offspring of affected individuals are at a 50% risk of inheriting the expanded <italic toggle="yes">TBP</italic> allele. The age of onset, severity, specific symptoms, and progression of the disease are variable and cannot be precisely predicted by family history or size of expansion. Prenatal diagnosis is possible for fetuses at 50% risk if the diagnosis has been confirmed in at least one relative; requests for prenatal testing of typically adult-onset diseases are uncommon.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="sca17.Diagnosis">
        <title>Diagnosis</title>
        <sec id="sca17.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>Spinocerebellar ataxia type 17 (SCA17) is suspected in individuals with the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Psychiatric symptoms or dementia</p>
            </list-item>
            <list-item>
              <p>Cerebellar ataxia or involuntary movement</p>
            </list-item>
          </list>
        </sec>
        <sec id="sca17.Molecular_Genetic_Testing">
          <title>Molecular Genetic Testing</title>
          <p><bold>Gene.</bold>
<italic toggle="yes">TBP</italic>, encoding the TATA-box-binding protein, is the only gene in which mutation is known to cause SCA17. The expansion of an imperfect CAG/CAA repeat is the only pathogenic variant observed [<xref ref-type="bibr" rid="sca17.REF.koide.1999.2047">Koide et al 1999</xref>, <xref ref-type="bibr" rid="sca17.REF.nakamura.2001.1441">Nakamura et al 2001</xref>]. Because both codons CAA and CAG encode a glutamine residue, the repeat results in a variable tract of glutamines.</p>
          <p><bold>Allele sizes.</bold> The structure of the repeat sequence is (CAG)<sub>3</sub> (CAA)<sub>3</sub> (CAG)<sub>x</sub> CAA CAG CAA (CAG)<sub>y</sub> CAA CAG. Allele sizes are determined by counting all triplet repeats; for example, if x=9 in (CAG)<sub>x</sub> and y=16 for (CAG)<sub>y</sub>, the total number of CAG/CAA repeats in the example above would be 36, translating to 36 glutamine residues in the protein.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Normal alleles.</bold> 25 to 40 CAG/CAA repeats</p>
            </list-item>
            <list-item>
              <p><bold>Mutable normal alleles.</bold> Not reported to date</p>
            </list-item>
            <list-item>
              <p><bold>Reduced penetrance alleles.</bold> 41 to 48 CAG/CAA repeats. An individual with an allele in this range may or may not develop symptoms. The significance of alleles of 41 and 44 repeats is particularly controversial because penetrance is estimated to be 50%, making genotype-phenotype correlations difficult. One symptomatic individual having 41 repeats and four symptomatic persons having 42 repeats were reported recently [<xref ref-type="bibr" rid="sca17.REF.nanda.2007.436">Nanda et al 2007</xref>, <xref ref-type="bibr" rid="sca17.REF.nolte.2010.1396">Nolte et al 2010</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Full penetrance alleles.</bold> 49 or greater CAG/CAA repeats. The largest repeat size reported to date is 66 [<xref ref-type="bibr" rid="sca17.REF.maltecca.2003.1441">Maltecca et al 2003</xref>].</p>
            </list-item>
          </list>
          <p><bold>CAA CAG CAA interruption.</bold> The CAA CAG CAA interruption between (CAG)<sub>x</sub> and (CAG)<sub>y</sub> is present in all expanded alleles that are stably transmitted (i.e., the allele size is unchanged during meiosis).</p>
          <p>The CAA CAG CAA interruption between (CAG)<sub>x</sub> and (CAG)<sub>y</sub> was absent in two families with allele size instability (i.e., change in allele size) during transmission [<xref ref-type="bibr" rid="sca17.REF.z_hlke.2001.160">Z&#x000fc;hlke et al 2001</xref>, <xref ref-type="bibr" rid="sca17.REF.maltecca.2003.1441">Maltecca et al 2003</xref>]. Thus, loss of this interruption may be a prerequisite of instability in SCA17 as in other diseases caused by repeat expansions [<xref ref-type="bibr" rid="sca17.REF.maltecca.2003.1441">Maltecca et al 2003</xref>, <xref ref-type="bibr" rid="sca17.REF.z_hlke.2003b.629">Z&#x000fc;hlke et al 2003b</xref>, <xref ref-type="bibr" rid="sca17.REF.z_hlke.2005.27">Z&#x000fc;hlke et al 2005</xref>].</p>
          <p>
            <bold>Clinical testing</bold>
          </p>
          <table-wrap id="sca17.T.summary_of_molecular_genetic_tes" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Spinocerebellar Ataxia Type 17</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_sca17.T.summary_of_molecular_genetic_tes_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_sca17.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_sca17.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Pathogenic Variants Detected&#x000a0;<sup>2</sup></th>
                  <th id="hd_h_sca17.T.summary_of_molecular_genetic_tes_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variant Detection Frequency by Test Method&#x000a0;<sup>3</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_sca17.T.summary_of_molecular_genetic_tes_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">TBP</italic>
                  </td>
                  <td headers="hd_h_sca17.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Targeted analysis for pathogenic variants</td>
                  <td headers="hd_h_sca17.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">CAG/CAA repeat expansion</td>
                  <td headers="hd_h_sca17.T.summary_of_molecular_genetic_tes_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">100%</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="sca17.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="sca17" object-id="sca17.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="sca17.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="sca17.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
              </fn>
              <fn id="sca17.TF.1.3">
                <label>3. </label>
                <p>The ability of the test method used to detect a variant that is present in the indicated gene</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="sca17.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>To confirm/establish the diagnosis in a proband,</bold> molecular genetic testing must reveal an expanded CAG/CAA repeat in <italic toggle="yes">TBP</italic>.</p>
          <p><bold>Predictive testing</bold> for at-risk asymptomatic adult family members requires prior confirmation of the diagnosis in an affected family member.</p>
          <p><bold>Prenatal diagnosis</bold> for at-risk pregnancies requires prior confirmation of the diagnosis in an affected family member.</p>
        </sec>
      </sec>
      <sec id="sca17.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="sca17.Clinical_Description">
          <title>Clinical Description</title>
          <p>The main symptoms of spinocerebellar ataxia type 17 (SCA17) are ataxia (95%), dementia (~90%), and involuntary movements (~70%), including chorea and dystonia (blepharospasm, torticollis, writer's cramp, foot dystonia) [<xref ref-type="bibr" rid="sca17.REF.cellini.2004.163">Cellini et al 2004</xref>, <xref ref-type="bibr" rid="sca17.REF.toyoshima.2004.281">Toyoshima et al 2004</xref>]. Psychiatric symptoms, pyramidal signs, and rigidity are common.</p>
          <p>Onset ranges from age three to 75 years (mean: 34.6 years) [<xref ref-type="bibr" rid="sca17.REF.stevanin.2008.170">Stevanin &#x00026; Brice 2008</xref>]. All individuals with full penetrance alleles develop neurologic and/or psychiatric symptoms by age 50 years [<xref ref-type="bibr" rid="sca17.REF.koide.1999.2047">Koide et al 1999</xref>; <xref ref-type="bibr" rid="sca17.REF.fujigasaki.2001.1939">Fujigasaki et al 2001</xref>; <xref ref-type="bibr" rid="sca17.REF.nakamura.2001.1441">Nakamura et al 2001</xref>; <xref ref-type="bibr" rid="sca17.REF.z_hlke.2001.160">Z&#x000fc;hlke et al 2001</xref>; <xref ref-type="bibr" rid="sca17.REF.silveira.2002.623">Silveira et al 2002</xref>; <xref ref-type="bibr" rid="sca17.REF.maltecca.2003.1441">Maltecca et al 2003</xref>; <xref ref-type="bibr" rid="sca17.REF.stevanin.2003.1599">Stevanin et al 2003</xref>; <xref ref-type="bibr" rid="sca17.REF.z_hlke.2003b.629">Z&#x000fc;hlke et al 2003b</xref>; <xref ref-type="bibr" rid="sca17.REF.bauer.2004.230">Bauer et al 2004</xref>; <xref ref-type="bibr" rid="sca17.REF.hagenah.2004.217">Hagenah et al 2004</xref>; <xref ref-type="bibr" rid="sca17.REF.oda.2004.209">Oda et al 2004</xref>; Toyoshima, personal observation].</p>
          <p>Although the disease course is variable, ataxia and psychiatric abnormalities are frequently the initial findings followed by involuntary movement, parkinsonism, dementia, and pyramidal signs.</p>
          <p>Brain MRI shows variable atrophy of the cerebrum, brain stem, and cerebellum (<xref ref-type="fig" rid="sca17.F1">Figure 1</xref>). Most people present with cerebellar atrophy. The age of the individual and the length of CAG/CAA repeat influence the degree of atrophy. For example, in older individuals &#x02013; even those with a small full-penetrance allele &#x02013; severe atrophy is present on brain MRI. High-intensity T<sub>2</sub>-weighted images and selective atrophy on caudate nucleus are not observed. Some correlation of region of brain atrophy with clinical characteristics is seen [<xref ref-type="bibr" rid="sca17.REF.lasek.2006.2341">Lasek et al 2006</xref>].</p>
          <p><bold>Neuropathology.</bold> The brain shows atrophy of the striatum (more apparent in the caudate nucleus) and cerebellum. Histologically, neuronal loss is observed in the striatum and Purkinje cell layer. Loss of cerebral cortical neurons is seen in some individuals.</p>
          <p>Immunohistochemistry for the expanded polyglutamine (polyQ) tracts shows diffuse labeling of the neuronal nucleoplasm.</p>
          <p>Note: Intranuclear inclusions are a much less common finding than diffuse labeling. No labeling is detectable in the cytoplasm or in the neuropil. Glial cell involvement is occasionally seen.</p>
          <p>In individuals who are homozygous for an expanded allele in the full-penetrance range, nuclear polyQ pathology involves other CNS regions including the cerebral cortex, thalamus, and brain stem [<xref ref-type="bibr" rid="sca17.REF.toyoshima.2004.281">Toyoshima et al 2004</xref>]. The abundant nuclear accumulation of polyQ in the cerebral cortices and subcortical nuclei (e.g., dorsomedian thalamic nucleus) are possibly associated with the prominent cognitive and behavioral decline in affected individuals.</p>
        </sec>
        <sec id="sca17.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <sec id="sca17.Heterozygotes">
            <title>Heterozygotes</title>
            <p><bold>Clinical features.</bold> The length of the CAG/CAA repeat in <italic toggle="yes">TBP</italic> correlates with the clinical features based on data available from 52 individuals (50 from the literature and two unreported) (<xref ref-type="table" rid="sca17.T.frequency_of_clinical_features_i">Table 2</xref>, <xref ref-type="fig" rid="sca17.F2">Figure 2</xref>). As the information reported in the literature was incomplete, the percentage of each symptom may be underestimated [<xref ref-type="bibr" rid="sca17.REF.koide.1999.2047">Koide et al 1999</xref>, <xref ref-type="bibr" rid="sca17.REF.fujigasaki.2001.1939">Fujigasaki et al 2001</xref>, <xref ref-type="bibr" rid="sca17.REF.nakamura.2001.1441">Nakamura et al 2001</xref>, <xref ref-type="bibr" rid="sca17.REF.z_hlke.2001.160">Z&#x000fc;hlke et al 2001</xref>, <xref ref-type="bibr" rid="sca17.REF.silveira.2002.623">Silveira et al 2002</xref>, <xref ref-type="bibr" rid="sca17.REF.maltecca.2003.1441">Maltecca et al 2003</xref>, <xref ref-type="bibr" rid="sca17.REF.rolfs.2003.367">Rolfs et al 2003</xref>, <xref ref-type="bibr" rid="sca17.REF.stevanin.2003.1599">Stevanin et al 2003</xref>, <xref ref-type="bibr" rid="sca17.REF.z_hlke.2003a.161">Z&#x000fc;hlke et al 2003a</xref>, <xref ref-type="bibr" rid="sca17.REF.bauer.2004.230">Bauer et al 2004</xref>, <xref ref-type="bibr" rid="sca17.REF.hagenah.2004.217">Hagenah et al 2004</xref>, <xref ref-type="bibr" rid="sca17.REF.oda.2004.209">Oda et al 2004</xref>]. Of note is the high proportion of individuals with psychiatric problems and chorea.</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>CAG/CAA repeat size from 43 to 50.</bold> More than 75% of individuals have intellectual deterioration; in some individuals intellectual problems and involuntary movements are the only signs. Psychiatric problems or dementia, parkinsonism, and chorea, a clinical constellation resembling Huntington disease, are more frequently observed in individuals with CAG/CAA repeats in this range than in individuals with larger repeats [<xref ref-type="bibr" rid="sca17.REF.stevanin.2003.1599">Stevanin et al 2003</xref>, <xref ref-type="bibr" rid="sca17.REF.bauer.2004.230">Bauer et al 2004</xref>, <xref ref-type="bibr" rid="sca17.REF.toyoshima.2004.281">Toyoshima et al 2004</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>CAG/CAA repeat size from 43-47.</bold> Individuals with 43-47 repeat size tend to have a parkisonian phenotype [<xref ref-type="bibr" rid="sca17.REF.kim.2009.1385">Kim et al 2009</xref>, <xref ref-type="bibr" rid="sca17.REF.chen.2010.375">Chen et al 2010</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>CAG/CAA repeat size from 50-60.</bold> All individuals have ataxia and 75% have reduced intellectual function. Pyramidal signs (e.g., increased deep tendon reflexes) and dystonia are more common than in those with smaller repeats.</p>
              </list-item>
              <list-item>
                <p><bold>CAG/CAA repeat size greater than 60.</bold> Two individuals with repeats in this size range have been reported. The largest CAG/CAA repeat is 66 repeats, observed in a familial case [<xref ref-type="bibr" rid="sca17.REF.maltecca.2003.1441">Maltecca et al 2003</xref>]. The child developed gait disturbance at age three years followed by spasticity, dementia, and psychiatric symptoms. The other child, who had a <italic toggle="yes">de novo</italic> CAG repeat expansion of 63 repeats, developed ataxia and intellectual deterioration at age six years followed later by spasticity [<xref ref-type="bibr" rid="sca17.REF.koide.1999.2047">Koide et al 1999</xref>]. Brain MRI showed severe atrophy in the cerebrum, cerebellum, and brain stem.</p>
              </list-item>
            </list>
            <table-wrap id="sca17.T.frequency_of_clinical_features_i" orientation="portrait" position="anchor">
              <label>Table 2. </label>
              <caption>
                <p>Frequency of Clinical Features in SCA17 Correlated with Repeat Size</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_sca17.T.frequency_of_clinical_features_i_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">CAG/CAA Repeat Size</th>
                    <th id="hd_h_sca17.T.frequency_of_clinical_features_i_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Ataxia</th>
                    <th id="hd_h_sca17.T.frequency_of_clinical_features_i_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Dementia / Psychiatric Symptoms</th>
                    <th id="hd_h_sca17.T.frequency_of_clinical_features_i_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Increased DTRs&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_sca17.T.frequency_of_clinical_features_i_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Dystonia</th>
                    <th id="hd_h_sca17.T.frequency_of_clinical_features_i_1_1_1_6" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Parkinsonism</th>
                    <th id="hd_h_sca17.T.frequency_of_clinical_features_i_1_1_1_7" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Chorea</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_sca17.T.frequency_of_clinical_features_i_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">43-49</td>
                    <td headers="hd_h_sca17.T.frequency_of_clinical_features_i_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">93%</td>
                    <td headers="hd_h_sca17.T.frequency_of_clinical_features_i_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">90%</td>
                    <td headers="hd_h_sca17.T.frequency_of_clinical_features_i_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">45%</td>
                    <td headers="hd_h_sca17.T.frequency_of_clinical_features_i_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">7%</td>
                    <td headers="hd_h_sca17.T.frequency_of_clinical_features_i_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">42%</td>
                    <td headers="hd_h_sca17.T.frequency_of_clinical_features_i_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">39%</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_sca17.T.frequency_of_clinical_features_i_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">&#x02265;50</td>
                    <td headers="hd_h_sca17.T.frequency_of_clinical_features_i_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">100%</td>
                    <td headers="hd_h_sca17.T.frequency_of_clinical_features_i_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">75%</td>
                    <td headers="hd_h_sca17.T.frequency_of_clinical_features_i_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">55%</td>
                    <td headers="hd_h_sca17.T.frequency_of_clinical_features_i_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">40%</td>
                    <td headers="hd_h_sca17.T.frequency_of_clinical_features_i_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">25%</td>
                    <td headers="hd_h_sca17.T.frequency_of_clinical_features_i_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">10%</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="sca17.TF.2.1">
                  <label>1. </label>
                  <p>DTR = deep tendon reflex</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
          <sec id="sca17.Homozygotes">
            <title>Homozygotes</title>
            <p>Four homozygous individuals and one compound heterozygous individual have been reported [<xref ref-type="bibr" rid="sca17.REF.z_hlke.2003b.629">Z&#x000fc;hlke et al 2003b</xref>, <xref ref-type="bibr" rid="sca17.REF.oda.2004.209">Oda et al 2004</xref>, <xref ref-type="bibr" rid="sca17.REF.toyoshima.2004.281">Toyoshima et al 2004</xref>, <xref ref-type="bibr" rid="sca17.REF.hire.2011.472">Hire et al 2011</xref>]. Four individuals who were homozygous for 47 and 48 CAG/CAA repeats had onset in the fourth decade, not unlike the onset age predicted for heterozygotes [<xref ref-type="bibr" rid="sca17.REF.z_hlke.2003b.629">Z&#x000fc;hlke et al 2003b</xref>, <xref ref-type="bibr" rid="sca17.REF.toyoshima.2004.281">Toyoshima et al 2004</xref>]. Their symptoms were severe and rapidly progressive, and in one individual differed from those of his parents, suggesting that the presence of two expanded alleles influences the severity and rate of progression of symptoms.</p>
          </sec>
        </sec>
        <sec id="sca17.Penetrance">
          <title>Penetrance</title>
          <p>The penetrance of alleles of 41 to 44 repeats is estimated at 50% and the penetrance of alleles of 45 to 48 repeats is estimated at greater than 80% [<xref ref-type="bibr" rid="sca17.REF.toyoshima.2004.281">Toyoshima et al 2004</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p>An individual with 41 CAG/CAA repeats developed ataxia at age 50 [<xref ref-type="bibr" rid="sca17.REF.nanda.2007.436">Nanda et al 2007</xref>]</p>
            </list-item>
            <list-item>
              <p>Four individuals with 42 CAG/CAA repeats developed a relatively benign phenotype consisting of mild gait ataxia, dysarthria, and dysdiadochokinesia [<xref ref-type="bibr" rid="sca17.REF.nolte.2010.1396">Nolte et al 2010</xref>].</p>
            </list-item>
            <list-item>
              <p>An individual with 43 CAG/CAA repeats developed ataxia with dementia at age 52 years [<xref ref-type="bibr" rid="sca17.REF.silveira.2002.623">Silveira et al 2002</xref>]; six individuals diagnosed with parkinsonism were found to have 43 CAG/CAA repeats [<xref ref-type="bibr" rid="sca17.REF.kim.2009.1385">Kim et al 2009</xref>].</p>
            </list-item>
            <list-item>
              <p>An individual with 46 CAG/CAA repeats developed symptoms at age 75 years, the latest onset observed to date [<xref ref-type="bibr" rid="sca17.REF.wu.2005.539">Wu et al 2005</xref>].</p>
            </list-item>
            <list-item>
              <p>Asymptomatic elderly individuals with 43 to 49 CAG/CAA repeats have also been reported [<xref ref-type="bibr" rid="sca17.REF.nakamura.2001.1441">Nakamura et al 2001</xref>, <xref ref-type="bibr" rid="sca17.REF.z_hlke.2003a.161">Z&#x000fc;hlke et al 2003a</xref>, <xref ref-type="bibr" rid="sca17.REF.oda.2004.209">Oda et al 2004</xref>, <xref ref-type="bibr" rid="sca17.REF.z_hlke.2005.27">Z&#x000fc;hlke et al 2005</xref>, <xref ref-type="bibr" rid="sca17.REF.mariotti.2007.1538">Mariotti et al 2007</xref>].</p>
            </list-item>
          </list>
          <p><bold>Age of onset.</bold> The correlation between the size of the CAG/CAA repeat and the age of onset in SCA17 (<xref ref-type="fig" rid="sca17.F3">Figure 3</xref>) is not as strong as in other disorders (<related-object link-type="booklink" source-id="gene" document-id="sca1" document-type="chapter">SCA1</related-object>, <related-object link-type="booklink" source-id="gene" document-id="sca2" document-type="chapter">SCA2</related-object>, <related-object link-type="booklink" source-id="gene" document-id="sca3" document-type="chapter">SCA3</related-object>, <related-object link-type="booklink" source-id="gene" document-id="sca6" document-type="chapter">SCA6</related-object>, <related-object link-type="booklink" source-id="gene" document-id="sca7" document-type="chapter">SCA7</related-object>, <related-object link-type="booklink" source-id="gene" document-id="huntington" document-type="chapter">Huntington disease</related-object>, <related-object link-type="booklink" source-id="gene" document-id="drpla" document-type="chapter">DRPLA</related-object>, <related-object link-type="booklink" source-id="gene" document-id="kennedy" document-type="chapter">SBMA</related-object> [Kennedy disease]) caused by expansion of a polyglutamine tract [<xref ref-type="bibr" rid="sca17.REF.rolfs.2003.367">Rolfs et al 2003</xref>, <xref ref-type="bibr" rid="sca17.REF.toyoshima.2004.281">Toyoshima et al 2004</xref>].</p>
        </sec>
        <sec id="sca17.Anticipation">
          <title>Anticipation</title>
          <p>Instability of the CAG repeat in germline transmission is not clear in SCA17 [<xref ref-type="bibr" rid="sca17.REF.fujigasaki.2001.1939">Fujigasaki et al 2001</xref>, <xref ref-type="bibr" rid="sca17.REF.nakamura.2001.1441">Nakamura et al 2001</xref>, <xref ref-type="bibr" rid="sca17.REF.shatunov.2004.496">Shatunov et al 2004</xref>]. CAG repeats in <italic toggle="yes">TBP</italic> have two distinct configurations, which are differentiated by the absence or presence of CAA interruptions. In German and Italian families, an absence of CAA interruptions resulting in longer pure tracts of CAG repeats was detected. It is of note that intergenerational instability and anticipation were documented in these families[ <xref ref-type="bibr" rid="sca17.REF.z_hlke.2001.160">Z&#x000fc;hlke et al 2001</xref>, <xref ref-type="bibr" rid="sca17.REF.maltecca.2003.1441">Maltecca et al 2003</xref>] CAA interruptions may serve as a limiting element for further expansion of CAG repeats in <italic toggle="yes">TBP</italic> [<xref ref-type="bibr" rid="sca17.REF.gao.2008.215">Gao et al 2008</xref>].</p>
          <p>The phenomenon termed anticipation, a trend toward an earlier age at onset and more severe disease manifestations in offspring of an affected individual, is infrequently documented in families with SCA17. In addition, because of low penetrance of the intermediate alleles (41 to 48 repeats), the age of onset, severity, specific symptoms, and progression of the disease are variable and cannot be predicted by family history or size of expansion.</p>
        </sec>
        <sec id="sca17.Prevalence">
          <title>Prevalence</title>
          <p>Fewer than 100 families with SCA17 have been reported.</p>
          <p>The prevalence of SCA17 in the Japanese population is estimated at 0.47:1,000,000. SCA17 accounts for approximately 0.3% of autosomal dominant SCA [<xref ref-type="bibr" rid="sca17.REF.maruyama.2002.578">Maruyama et al 2002</xref>].</p>
          <p>The minimum prevalence of SCA17 in northeast England is 0.16:100,000 [<xref ref-type="bibr" rid="sca17.REF.craig.2005.105">Craig et al 2005</xref>].</p>
          <p>In a study of the Yugoslav population, none of the 115 individuals with autosomal dominant cerebellar ataxia or simplex cases of adult-onset ataxia had SCA17 [<xref ref-type="bibr" rid="sca17.REF.alendar.2004.185">Alendar et al 2004</xref>].</p>
          <p>The prevalence of SCA17 may be underestimated because some individuals with SCA17 have a phenotype similar to that of <related-object link-type="booklink" source-id="gene" document-id="huntington" document-type="chapter">Huntington disease</related-object>.</p>
        </sec>
      </sec>
      <sec id="sca17.Genetically_Related_Allelic_Disord">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No other phenotypes are known to be associated with mutation of <italic toggle="yes">TBP</italic>.</p>
      </sec>
      <sec id="sca17.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of spinocerebellar ataxia type 17 (SCA17) includes many of the other hereditary ataxias that are summarized in the <related-object link-type="booklink" source-id="gene" document-id="ataxias" document-type="chapter">Hereditary Ataxia Overview</related-object> and described in detail for specific ataxias, including <related-object link-type="booklink" source-id="gene" document-id="sca1" document-type="chapter">SCA1</related-object>, <related-object link-type="booklink" source-id="gene" document-id="sca2" document-type="chapter">SCA2</related-object>, <related-object link-type="booklink" source-id="gene" document-id="sca3" document-type="chapter">SCA3</related-object>, and <related-object link-type="booklink" source-id="gene" document-id="sca7" document-type="chapter">SCA7</related-object>.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="drpla" document-type="chapter">DRPLA</related-object> is a progressive disorder of ataxia, choreoathetosis, and dementia or character changes in adults and ataxia, myoclonus, epilepsy, and progressive intellectual deterioration in children.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="huntington" document-type="chapter">Huntington disease</related-object> (HD) also needs to be considered [<xref ref-type="bibr" rid="sca17.REF.rolfs.2003.367">Rolfs et al 2003</xref>]. HD is a progressive disorder of motor, cognitive, and psychiatric disturbances. The mean age of onset is 35 to 44 years and the median survival is 15 to 18 years after onset.</p>
        <p><xref ref-type="bibr" rid="sca17.REF.bauer.2004.230">Bauer et al [2004]</xref> reported nine individuals with <italic toggle="yes">TBP</italic> alleles larger than 45 CAG/CAA repeats among 1,712 individuals with Huntington disease-like (HDL), and observed that CAG/CAA repeat expansions in <italic toggle="yes">TBP</italic> represented a more common monogenic cause for a HD-like phenotype than Huntington disease-like 1 (HDL-1) [<xref ref-type="bibr" rid="sca17.REF.xiang.1998.1431">Xiang et al 1998</xref>] or <related-object link-type="booklink" source-id="gene" document-id="hd-l2" document-type="chapter">Huntington disease-like 2</related-object> (HDL-2) [<xref ref-type="bibr" rid="sca17.REF.margolis.2001.373">Margolis et al 2001</xref>]. Therefore SCA17 is also referred to as Huntington disease-like disorder 4 (HDL-4) [<xref ref-type="bibr" rid="sca17.REF.stevanin.2003.1599">Stevanin et al 2003</xref>, <xref ref-type="bibr" rid="sca17.REF.schneider.2007.517">Schneider et al 2007</xref>, <xref ref-type="bibr" rid="sca17.REF.harbo.2009.777">Harbo et al 2009</xref>].</p>
        <p><xref ref-type="bibr" rid="sca17.REF.lin.2007.246">Lin et al [2007]</xref> reported an individual with SCA17 whose findings of ataxia, autonomic dysfunction, parkinsonism, supranuclear palsy, and cognitive impairment resembled multiple system atrophy.</p>
      </sec>
      <sec id="sca17.Management">
        <title>Management</title>
        <sec id="sca17.Evaluations_Following_Initial_Diag">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease in an individual diagnosed with spinocerebellar ataxia type 17 (SCA17), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Neuropsychological testing to evaluate for dementia and/or psychiatric disturbance</p>
            </list-item>
            <list-item>
              <p>Brain MRI to evaluate areas and degree of atrophy</p>
            </list-item>
            <list-item>
              <p>Neurology consultation, if not completed prior to initial diagnosis</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="sca17.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>The following are appropriate:</p>
          <list list-type="bullet">
            <list-item>
              <p>Treatment of psychiatric problems with appropriate psychotropic medications</p>
            </list-item>
            <list-item>
              <p>Treatment of seizures with antiepileptic drugs (AEDs)</p>
            </list-item>
            <list-item>
              <p>Adaptation of environment and care to the level of dementia</p>
            </list-item>
            <list-item>
              <p>Treatment of dystonia with local injections of botulinum toxin</p>
            </list-item>
          </list>
        </sec>
        <sec id="sca17.Prevention_of_Secondary_Complicati">
          <title>Prevention of Secondary Complications</title>
          <p>The side effects of psychotropic medications and AEDs (e.g., depression, sedation, nausea, restlessness, headache, neutropenia, and tardive dsykinesia) can be major secondary complications in persons with SCA17. For some individuals, the side effects of certain therapeutics may be worse than the symptoms of the disease; such individuals may benefit from total or intermittent discontinuation of the treatment or reduction in dose.</p>
        </sec>
        <sec id="sca17.Surveillance">
          <title>Surveillance</title>
          <p>Affected individuals should be followed annually or semiannually by a neurologist or more frequently if symptoms are progressing rapidly, as may happen in the advanced stages [<xref ref-type="bibr" rid="sca17.REF.toyoshima.2004.281">Toyoshima et al 2004</xref>].</p>
        </sec>
        <sec id="sca17.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Agents with sedative/hypnotic properties, such as ethanol or certain medications, may markedly increase incoordination.</p>
        </sec>
        <sec id="sca17.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="sca17.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="sca17.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>Affected women may be on medications (e.g., antiepileptics) to control the symptoms of SCA17. Because some medications can have adverse effects on the developing fetus, a thorough discussion of the medical benefits vs. risks to the fetus of such medications before pregnancy (or, in the case of an unplanned pregnancy, immediately after pregnancy is determined) is appropriate.</p>
        </sec>
        <sec id="sca17.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="sca17.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="sca17.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Spinocerebellar ataxia type 17 (SCA17) is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="sca17.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband *</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Approximately 50% of individuals diagnosed with SCA17 have an affected parent.</p>
            </list-item>
            <list-item>
              <p>Thirty-eight percent of individuals with SCA17 are simplex cases (i.e., only one affected person in the family). In most cases, molecular genetic testing of the parents has not been performed.</p>
            </list-item>
            <list-item>
              <p>A proband with SCA17 may have the disorder as a result of a <italic toggle="yes">de novo</italic> expansion in <italic toggle="yes">TBP</italic>. The proportion of cases caused by <italic toggle="yes">de novo</italic> expansions is unknown [<xref ref-type="bibr" rid="sca17.REF.koide.1999.2047">Koide et al 1999</xref>, <xref ref-type="bibr" rid="sca17.REF.shatunov.2004.496">Shatunov et al 2004</xref>].</p>
            </list-item>
            <list-item>
              <p>If an expansion (&#x0003e;42 CAG/CAA repeats) of <italic toggle="yes">TBP</italic> cannot be detected in the DNA of either parent, two possible explanations are germline mosaicism in a parent or a <italic toggle="yes">de novo</italic> expansion in the proband. Expansion from a mutable normal allele in the parent is also a possibility, although no instances have been reported.</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant of <italic toggle="yes">TBP</italic> include molecular genetic testing of the gene.</p>
            </list-item>
          </list>
          <p>Note: Although approximately 50% of individuals diagnosed with SCA17 have an affected parent, the family history may appear to be negative because of failure to recognize the disorder in family members because of its extremely variable phenotype, early death of the parent before the onset of symptoms, late onset of the disease in the affected parent, or reduced penetrance in a parent.</p>
          <list list-type="bullet">
            <list-item>
              <label>*</label>
              <p>Based on the family history of the 37 reported families with affected individuals and an unreported family with two affected individuals [<xref ref-type="bibr" rid="sca17.REF.koide.1999.2047">Koide et al 1999</xref>; <xref ref-type="bibr" rid="sca17.REF.fujigasaki.2001.1939">Fujigasaki et al 2001</xref>; <xref ref-type="bibr" rid="sca17.REF.nakamura.2001.1441">Nakamura et al 2001</xref>; <xref ref-type="bibr" rid="sca17.REF.z_hlke.2001.160">Z&#x000fc;hlke et al 2001</xref>; <xref ref-type="bibr" rid="sca17.REF.silveira.2002.623">Silveira et al 2002</xref>; <xref ref-type="bibr" rid="sca17.REF.maltecca.2003.1441">Maltecca et al 2003</xref>; <xref ref-type="bibr" rid="sca17.REF.rolfs.2003.367">Rolfs et al 2003</xref>; <xref ref-type="bibr" rid="sca17.REF.stevanin.2003.1599">Stevanin et al 2003</xref>; <xref ref-type="bibr" rid="sca17.REF.z_hlke.2003a.161">Z&#x000fc;hlke et al 2003a</xref>; <xref ref-type="bibr" rid="sca17.REF.bauer.2004.230">Bauer et al 2004</xref>; <xref ref-type="bibr" rid="sca17.REF.hagenah.2004.217">Hagenah et al 2004</xref>; <xref ref-type="bibr" rid="sca17.REF.oda.2004.209">Oda et al 2004</xref>; Toyoshima, personal observations]</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband's parents.</p>
            </list-item>
            <list-item>
              <p>If one of the parents of the proband has an expanded <italic toggle="yes">TBP</italic> allele, the risk to the sibs of inheriting the expanded CAG/CAA allele is 50%. The age of onset, severity, specific symptoms, and progression of the disease are variable and cannot be precisely predicted by family history or size of expansion.</p>
            </list-item>
            <list-item>
              <p>If an expansion (&#x0003e;42 CAG/CAA repeats) of <italic toggle="yes">TBP</italic> cannot be detected in the DNA of either parent, the risk to sibs is low but greater than that of the general population because of the possibility of germline mosaicism.</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Each child of an individual with SCA17 has a 50% chance of inheriting the expanded <italic toggle="yes">TBP</italic> allele.</p>
            </list-item>
            <list-item>
              <p>The age of onset, severity, specific symptoms, and progression of the disease are variable and cannot be precisely predicted by family history or size of expansion.</p>
            </list-item>
          </list>
          <p><bold>Other family members of a proband.</bold> The risk to other family members depends on the genetic status of the proband's parents. If a parent is affected or has an expanded <italic toggle="yes">TBP</italic> allele, his or her family members are at risk.</p>
        </sec>
        <sec id="sca17.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has gene expansion or clinical evidence of the disorder, it is likely that the proband has a <italic toggle="yes">de novo</italic> pathogenic variant. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>Testing of at-risk asymptomatic adults</bold> at risk for SCA17 is possible using the techniques described in <xref ref-type="sec" rid="sca17.Molecular_Genetic_Testing">Molecular Genetic Testing</xref>. Such testing is not useful in predicting age of onset, severity, type of symptoms, or rate of progression in asymptomatic individuals. When testing at-risk individuals for SCA17, an affected family member should be tested first to confirm the molecular diagnosis of SCA17 in the family.</p>
          <p>Testing for the pathogenic expansion in the absence of definite symptoms of the disease is predictive testing. At-risk asymptomatic adult family members may seek testing in order to make personal decisions regarding reproduction, financial matters, and career planning. Others may have different motivations including simply "the need to know."</p>
          <p>Testing of asymptomatic at-risk adult family members usually involves pretest interviews in which the motives for requesting the test, the individual's knowledge of SCA17, the possible impact of positive and negative test results, and neurologic status are assessed. Those seeking testing should be counseled about possible problems that they may encounter with regard to health, life, and disability insurance coverage, employment and educational discrimination, and changes in social and family interaction. Another issue to consider is the implications for the at-risk status of other family members. Informed consent should be procured and records kept confidential. Individuals with a positive test result need arrangements for long-term follow-up and genetic counseling.</p>
          <p><bold>Testing of at-risk asymptomatic individuals younger than age 18 years.</bold> Consensus holds that individuals younger than age 18 years at risk for adult-onset disorders should not have testing in the absence of symptoms. The principal arguments against such testing are that it removes the individual's choice to know or not know this information, it raises the possibility of stigmatization within the family and in other social settings, and it could have serious educational and career implications. Individuals younger than 18 years of age who are symptomatic usually benefit from having a specific diagnosis established. See also the National Society of Genetic Counselors <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">position statement</ext-link> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">policy statement</ext-link>: ethical and policy issues in genetic testing and screening of children.</p>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="sca17.Prenatal_Testing_and_Preimplantati">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">TBP</italic> pathogenic variant has been identified in an affected family member, prenatal diagnosis for a pregnancy at increased risk and preimplantation genetic diagnosis for SCA17 are possible.</p>
          <p>Requests for prenatal testing for (typically) adult-onset conditions such as SCA17 are not common. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="sca17.Resources">
        <title>Resources</title>
      </sec>
      <sec id="sca17.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">TBP</italic> has eight exons (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_003194.4">NM_003194.4</ext-link>); the CAG/CAA repeat tract is in exon 3. Two transcript variants encoding different protein isoforms were identified (see <related-object source-id="gene" document-id="sca17" object-id="sca17.molgen.TA">Table A</related-object>, <bold>Gene</bold>).</p>
        <p><bold>Benign variants.</bold> Normal variants have between 25 and 42 CAG/CAA repeats.</p>
        <p><bold>Pathogenic variants.</bold> The CAG/CAA repeat length in individuals with <italic toggle="yes">TBP</italic> ranges from 43 to 66 repeats.</p>
        <p><bold>Normal gene product.</bold> TATA-box-binding protein (TBP) is also called transcription factor IID (TFIID). Human TBP has 339 amino acids (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_003185.1">NP_003185.1</ext-link>) and a molecular size of 37.8 kd. TBP is an important general transcription initiation factor and is the DNA-binding subunit of RNA polymerase II transcription factor D, the multi-subunit complex crucial for the expression of most genes.</p>
        <p><bold>Abnormal gene product.</bold> Because TBP is a fundamental transcription factor expressed ubiquitously in all organs including the CNS, the question of whether loss of TBP function plays a role in the pathogenesis of SCA17 remains to be addressed. In a homozygote, however, no abnormality was observed in growth, and pathologic examination showed no specific changes in the visceral organs [<xref ref-type="bibr" rid="sca17.REF.toyoshima.2004.281">Toyoshima et al 2004</xref>]. Taking into consideration the ubiquitous presence of TBP, the selective neuronal degeneration suggests no significant loss of protein function in individuals with SCA17.</p>
      </sec>
      <sec id="sca17.References">
        <title>References</title>
        <sec id="sca17.Published_GuidelinesConsensus_Stat">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="sca17.Published_GuidelinesConsensus_Stat.reflist0">
            <ref id="sca17.REF1">
              <mixed-citation publication-type="web">Committee on Bioethics, Committee on Genetics, and American College of Medical Genetics and Genomics Social, Ethical, Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">online</ext-link>. 2013. Accessed 3-2-17.</mixed-citation>
            </ref>
            <ref id="sca17.REF2">
              <mixed-citation publication-type="web">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset disorders. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">online</ext-link>. 2012. Accessed 3-2-17.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="sca17.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="sca17.Literature_Cited.reflist0">
            <ref id="sca17.REF.alendar.2004.185">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alendar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Euljkovic</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savic</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Djarmati</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keckarevic</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ristic</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dragasevic</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kosic</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romac</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Spinocerebellar ataxia type 17 in the Yugoslav population.</article-title>
                <source>Acta Neurol Scand</source>
                <volume>109</volume>
                <fpage>185</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">14763955</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.bauer.2004.230">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bauer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laccone</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rolfs</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wullner</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bosch</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peters</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liebscher</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheible</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Epplen</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holinski-Feder</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weirich-Schwaiger</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris-Rosendahl</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrich</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riess</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Trinucleotide repeat expansion in SCA17/TBP in white patients with Huntington's disease-like phenotype.</article-title>
                <source>J Med Genet</source>
                <volume>41</volume>
                <fpage>230</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">14985389</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.cellini.2004.163">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cellini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forleo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nacmias</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tedde</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bagnoli</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piacentini</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sorbi</surname>
                    <given-names>S.</given-names>
                  </name>
                </person-group>
                <article-title>Spinocerebellar ataxia type 17 repeat in patients with Huntington's disease-like and ataxia.</article-title>
                <source>Ann Neurol.</source>
                <year>2004</year>
                <month>Jul</month>
                <volume>56</volume>
                <issue>1</issue>
                <fpage>163</fpage>
                <lpage>author reply 163-4</lpage>
                <pub-id pub-id-type="pmid">15236416</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.chen.2010.375">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soong</surname>
                    <given-names>BW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fung</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hsu</surname>
                    <given-names>WC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>PY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>FL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>CY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee-Chen</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>YR</given-names>
                  </name>
                </person-group>
                <article-title>SCA17 repeat expansion: mildly expanded CAG/CAA repeat alleles in neurological disorders and the funvtional implications.</article-title>
                <source>Clin Chim Acta</source>
                <year>2010</year>
                <volume>411</volume>
                <fpage>375</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">20004653</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.craig.2005.105">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Craig</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keers</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walls</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Curtis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Minimum prevalence of spinocerebellar ataxia 17 in the north east of England.</article-title>
                <source>J Neurol Sci</source>
                <volume>239</volume>
                <fpage>105</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16223509</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.fujigasaki.2001.1939">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fujigasaki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Deyn</surname>
                    <given-names>PP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camuzat</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deffond</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevanin</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dermaut</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Broeckhoven</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durr</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia.</article-title>
                <source>Brain</source>
                <volume>124</volume>
                <fpage>1939</fpage>
                <lpage>47</lpage>
                <pub-id pub-id-type="pmid">11571212</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.gao.2008.215">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gao</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coolbaugh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Z&#x000fc;lke</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rasmussen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siciliano</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashizawa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>X</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Instability of expanded CAG/CAA repeats in spinocerebellar ataxia type 17.</article-title>
                <source>Europ J Hum Genet</source>
                <volume>16</volume>
                <fpage>215</fpage>
                <lpage>222</lpage>
                <pub-id pub-id-type="pmid">18043721</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.hagenah.2004.217">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hagenah</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuhlke</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hellenbroich</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heide</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Focal dystonia as a presenting sign of spinocerebellar ataxia 17.</article-title>
                <source>Mov Disord</source>
                <volume>19</volume>
                <fpage>217</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">14978680</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.harbo.2009.777">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Harbo</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finsterer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baets</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Broeckhoven</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Donato</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fontaine</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lossos</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mariotti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sch&#x000f6;ls</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinazzola</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szolnoki</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tabrizi</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tallaksen</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeviani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burgunder</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasser</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>EFNS. EFNS guidelines on the molecular diagnosis of neurogenetic disorders: general issues, Huntington's disease, Parkinson's disease and dystonias.</article-title>
                <source>Eur J Neurol.</source>
                <year>2009</year>
                <volume>16</volume>
                <fpage>777</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">19469830</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.hire.2011.472">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hire</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katrak</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vadya</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Radhakrishnan</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seshadri</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Spinocerebellar ataxia type 17 in Indian patients: two cases of homozygous expansions.</article-title>
                <source>Clin Genet</source>
                <volume>80</volume>
                <fpage>472</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">21108634</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.kim.2009.1385">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>SY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>YK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoon</surname>
                    <given-names>KY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>JY</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Spinocerebellar ataxia type 17 mutation as a causative and susceptibility gene in parkinsonism.</article-title>
                <source>Neurology</source>
                <volume>72</volume>
                <fpage>1385</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19380697</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.koide.1999.2047">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Koide</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimohata</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikeuchi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maruyama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease?</article-title>
                <source>Hum Mol Genet</source>
                <volume>8</volume>
                <fpage>2047</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">10484774</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.lasek.2006.2341">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lasek</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lencer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaser</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hagenah</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolters</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kock</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinlechner</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuhlke</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nitschke</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brockmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rolfs</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Binkofski</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Morphological basis for the spectrum of clinical deficits in spinocerebellar ataxia 17 (SCA17).</article-title>
                <source>Brain</source>
                <volume>129</volume>
                <fpage>2341</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">16760196</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.lin.2007.246">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>IS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee-Chen</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shan</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gwinn-Hardy</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>The SCA17 phenotype can include features of MSA-C, PSP and cognitive impairment.</article-title>
                <source>Parkinsonism Relat Disord</source>
                <volume>13</volume>
                <fpage>246</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16793320</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.maltecca.2003.1441">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Maltecca</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filla</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castaldo</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coppola</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fragassi</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carella</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruni</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cocozza</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casari</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Servadio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Michele</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Intergenerational instability and marked anticipation in SCA-17.</article-title>
                <source>Neurology</source>
                <volume>61</volume>
                <fpage>1441</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">14638975</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.margolis.2001.373">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Margolis</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Hearn</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willour</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holmes</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franz</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Callahan</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hwang</surname>
                    <given-names>HS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Troncoso</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion.</article-title>
                <source>Ann Neurol.</source>
                <volume>50</volume>
                <fpage>373</fpage>
                <lpage>80</lpage>
              </element-citation>
            </ref>
            <ref id="sca17.REF.mariotti.2007.1538">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mariotti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alpini</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fancellu</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soliveri</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grisoli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ravaglia</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lovati</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fetoni</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giaccone</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castucci</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taroni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gellera</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Donato</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Spinocerebellar ataxia type 17 (SCA 17): oculomotor phenotype and clinical characterization of 15 Italian patients.</article-title>
                <source>J Neurol</source>
                <volume>254</volume>
                <fpage>1538</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">17934876</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.maruyama.2002.578">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Maruyama</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Izumi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morino</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toji</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawakami</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Difference in disease-free survival curve and regional distribution according to subtype of spinocerebellar ataxia: a study of 1,286 Japanese patients.</article-title>
                <source>Am J Med Genet</source>
                <volume>114</volume>
                <fpage>578</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">12116198</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.nakamura.2001.1441">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeong</surname>
                    <given-names>SY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uchihara</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagashima</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagashima</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikeda</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanazawa</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein.</article-title>
                <source>Hum Mol Genet</source>
                <volume>10</volume>
                <fpage>1441</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11448935</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.nanda.2007.436">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nanda</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwankhaus</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Metzer</surname>
                    <given-names>WS</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Case of spinocerebellar ataxia type 17 (SCA 17) associated with only 41 repeats of the TATA-binding protein (TBP) gene.</article-title>
                <source>Mov Disord</source>
                <volume>22</volume>
                <fpage>436</fpage>
                <pub-id pub-id-type="pmid">17149738</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.nolte.2010.1396">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nolte</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobanski</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wi&#x000df;en</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Regula</surname>
                    <given-names>JU</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lichy</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>U</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Spinocerebellar ataxia type 17 associated with an expansion of 42 glutamine residues in TATA-box binding protein gene.</article-title>
                <source>J Neurol Neurosurg Psychiatry</source>
                <volume>81</volume>
                <fpage>1396</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">20587494</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.oda.2004.209">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maruyama</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Komure</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morino</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terasawa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Izumi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imamura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yasuda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ichikawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumoto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawakami</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Possible reduced penetrance of expansion of 44 to 47 CAG/CAA repeats in the TATA-binding protein gene in spinocerebellar ataxia type 17.</article-title>
                <source>Arch Neurol</source>
                <volume>61</volume>
                <fpage>209</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">14967767</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.rolfs.2003.367">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rolfs</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koeppen</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bauer</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bauer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buhlmann</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schols</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riess</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17).</article-title>
                <source>Ann Neurol</source>
                <volume>54</volume>
                <fpage>367</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">12953269</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.schneider.2007.517">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhatia</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>The Huntington&#x02019;s disease-like syndromes: what to consider in patients with a negative Huntington&#x02019;s disease gene test.</article-title>
                <source>Nat Clin Pract Neurol</source>
                <volume>3</volume>
                <fpage>517</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">17805246</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.shatunov.2004.496">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shatunov</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fridman</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pagan</surname>
                    <given-names>FI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leib</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singleton</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hallett</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldfarb</surname>
                    <given-names>LG</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Small de novo duplication in the repeat region of the TATA-box-binding protein gene manifest with a phenotype similar to variant Creutzfeldt-Jakob disease.</article-title>
                <source>Clin Genet</source>
                <volume>66</volume>
                <fpage>496</fpage>
                <lpage>501</lpage>
                <pub-id pub-id-type="pmid">15521976</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.silveira.2002.623">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Silveira</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miranda</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guimaraes</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moreira</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alonso</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendonca</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferro</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinto-Basto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coelho</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferreirinha</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poirier</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parreira</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vale</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Januario</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbot</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuna</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barros</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koide</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holmes</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Margolis</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jardim</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pandolfo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coutinho</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sequeiros</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Trinucleotide repeats in 202 families with ataxia: a small expanded (CAG)n allele at the SCA17 locus.</article-title>
                <source>Arch Neurol</source>
                <volume>59</volume>
                <fpage>623</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11939898</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.stevanin.2008.170">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stevanin</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Spinocerebellar ataxia 17 (SCA 17) and Huntington&#x02019;s disease-like 4 (HDL4).</article-title>
                <source>The Cerebellum</source>
                <volume>7</volume>
                <fpage>170</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">18418687</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.stevanin.2003.1599">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stevanin</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujigasaki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lebre</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camuzat</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeannequin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dode</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>San</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellance</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durr</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes.</article-title>
                <source>Brain</source>
                <volume>126</volume>
                <fpage>1599</fpage>
                <lpage>603</lpage>
                <pub-id pub-id-type="pmid">12805114</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.toyoshima.2004.281">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Toyoshima</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Onodera</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimohata</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inenaga</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujita</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morita</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>SCA 17 homozygote showing Huntington's disease-like phenotype.</article-title>
                <source>Ann Neurol</source>
                <volume>55</volume>
                <fpage>281</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">14755733</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.wu.2005.539">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>YR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fung</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee-Chen</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gwinn-Hardy</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ro</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hsieh-Li</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>HY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>CY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>CM</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Analysis of polyglutamine-coding repeats in the TATA-binding protein in different neurodegenerative diseases.</article-title>
                <source>J Neural Transm</source>
                <volume>112</volume>
                <fpage>539</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">15365789</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.xiang.1998.1431">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Xiang</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Almqvist</surname>
                    <given-names>EW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huq</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lundin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayden</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edstrom</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anvret</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>Z</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>A Huntington disease-like neurodegenerative disorder maps to chromosome 20p.</article-title>
                <source>Am J Hum Genet</source>
                <volume>63</volume>
                <fpage>1431</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9792871</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.z_hlke.2005.27">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Z&#x000fc;hlke</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalski</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwinger</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finckh</surname>
                    <given-names>U</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Spinocerebellar ataxia type 17: report of a family with reduced penetrance of an unstable Gln49 TBP allele, haplotype analysis supporting a founder effect for unstable alleles and comparative analysis of SCA17 genotypes.</article-title>
                <source>BMC Med Genet.</source>
                <volume>6</volume>
                <fpage>27</fpage>
                <pub-id pub-id-type="pmid">15989694</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.z_hlke.2003a.161">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Z&#x000fc;hlke</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gehlken</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hellenbroich</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwinger</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000fc;rk</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2003a</year>
                <article-title>Phenotypical variability of expanded alleles in the TATA-binding protein gene. Reduced penetrance in SCA17?</article-title>
                <source>J Neurol.</source>
                <volume>250</volume>
                <fpage>161</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">12574945</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.z_hlke.2001.160">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Z&#x000fc;hlke</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hellenbroich</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalski</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kononowa</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hagenah</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vieregge</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riess</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwinger</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Different types of repeat expansion in the TATA-binding protein gene are associated with a new form of inherited ataxia.</article-title>
                <source>Eur J Hum Genet.</source>
                <volume>9</volume>
                <fpage>160</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">11313753</pub-id>
              </element-citation>
            </ref>
            <ref id="sca17.REF.z_hlke.2003b.629">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Z&#x000fc;hlke</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spranger</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spranger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voigt</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lanz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gehlken</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hinrichs</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwinger</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2003b</year>
                <article-title>SCA17 caused by homozygous repeat expansion in TBP due to partial isodisomy 6.</article-title>
                <source>Eur J Hum Genet.</source>
                <volume>11</volume>
                <fpage>629</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">12891385</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="sca17.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="sca17.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>17 May 2012 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>1 August 2007 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>29 March 2005 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>24 August 2004 (yt) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="sca17.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Number of CAG/CAA repeats versus age of individuals with SCA17</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="sca17-Image001" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="sca17.F2" orientation="portrait">
          <label>Figure 2. </label>
          <caption>
            <p>The clinical features in SCA17 depend on the length of CAG/CAA repeats. The clinical features of SCA17 in each case are denoted by letter. For example, A-E denotes ataxia with parkinsonism. A = ataxia D = dementia or psychiatric symptoms P = pyramidal signs E = parkinsonism or involuntary movement</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="sca17-Image002" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="sca17.F3" orientation="portrait">
          <label>Figure 3. </label>
          <caption>
            <p>Correlation in SCA17 between age at onset and length of CAG/CAA repeat</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="sca17-Image003" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
